Latest news for Veridis Environment (OTC:VRDDF) Stock

Veridis Environment Ltd focuses on developing and implementing services and ventures in its core business waste, water, and energy. The company provides advanced waste collection services to local authorities, organizations, and industry.

VERIDIS ENVIRONMENT LTD by Veridis Environment Ltd.

Veridis Environment Ltd

Many are sounding the alarms over Elon Musk's recent access to the <a href="https://www.benzinga.com/news/legal/25/02/43539572/musk-allies-face-treasury-data-limits-as-judge-steps-in">U.S. Department of Treaury's payment system</a>, which is responsible for handling over $6 trillion in annual federal payments. A large concern is surrounding Musk's access to millions of American's data and payments that directly affect their well-being, like Social Security, Medicare, and other government benefits.&nbsp;
While the Treasury Department insists that no payments have been delayed or altered, advocacy groups and lawmakers are warning of potential risks.&nbsp;
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
<h2 class="wp-block-heading">Why Changed and Why It Matters</h2>
The recently created Department of Government Efficiency (DOGE), which Musk is leading, was recently granted access to the Treasury Department's payment infrastructure as part of its efforts to minimize waste in government spending. Allowing the access has sparked outroar from lawmakers, advocacy groups, and citizens across the country, with many questioning the legality of such a move and how it could impact critical federal benefits for Americans.&nbsp;
<a href="https://home.treasury.gov/news/press-releases/sb0009">According to a letter</a> sent by the Treasury Department to Congress, DOGE now has "read-only" access, meaning Musk's team shouldn't be able to directly modify or stop payments. However, the concern remains on what his level of access could mean in the long run.&nbsp;
The president and CEO of the National Committee to Preserve Social Security and Medicare, Max Richtman, shared his strong opposition to Musk's access to the payment system. "Social Security beneficiaries and their families have every reason to be alarmed by Elon Musk's takeover of the U.S. Department of Treasury's payment system…Seniors, their families, and people with disabilities most certainly cannot trust Trump and Musk with their crucial federal benefits — or their personal data," he <a href="https://www.ncpssm.org/documents/latest-news/social-security-beneficiaries-cant-trust-musk-with-payments-personal-data/">said on the organization's website</a>.&nbsp;
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-nancy-pelosi">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000</a>
<h2 class="wp-block-heading">Lawmakers Raise Red Flags</h2>
Democratic lawmakers have expressed serious concern about DOGE's authority. U.S. Sen <a href="https://www.benzinga.com/news/25/02/43474551/elon-musk-says-elizabeth-warren-is-meddling-with-trillions-in-us-treasury-via-unqualified-flunkies">Elizabeth Warren</a> of Massachuseetts <a href="https://x.com/ewarren/status/1886505257649242388">took to X</a> to raise her concerns about the move, calling it "extraordinarily dangerous."&nbsp; She noted that millions of Americans depend on uninterrupted payments from the government for their financial well-being.&nbsp;
Lindsay Owens, executive director of Groundwork Collaborative, <a href="https://www.cnbc.com/2025/02/05/how-musks-access-to-treasury-system-may-impact-social-security.html">spoke with CNBC</a> and described the takeover as a "five-alarm fire," stating that as a private citizen with no official government role, Musk was given access to this sensitive system. The White House has said Musk is a <a href="https://www.justice.gov/jmd/ethics/summary-government-ethics-rules-special-government-employees">special government employee</a>.&nbsp;
Complicating the issue further, <a href="https://edition.cnn.com/2025/02/06/politics/elon-musk-treasury-department-payment-system/index.html">CNN reported</a> that Musk's associates at DOGE have attempted to influence federal payments. The network obtained emails showing top DOGE officials attempting to block U.S. Agency for International Development spending, just days after President Donald Trump's inauguration last month. This leaves government officials and citizens alike questioning whether similar moves may occur with <a href="https://www.benzinga.com/personal-finance/25/02/43464483/protect-billionaires-bottom-lines-dnc-criticizes-trumps-social-security-agenda">Social Security</a> and other domestic programs.&nbsp;
Trending: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
<h2 class="wp-block-heading">The Treasury Department's Response</h2>
Despite the concerns, the Treasury Department issued a letter to Congress stating that Social Security and Medicare payments have been processed as usual. A White House official stated that DOGE is only looking to restructure the payment system according to the President's goals and executive order, which currently don't include any disruption to Social Security.&nbsp;
However, <a href="https://www.benzinga.com/news/legal/25/02/43542558/trumps-push-to-reshape-federal-workforce-stalls-in-court">federal worker buyouts</a> under the Trump administration could indirectly impact Social Security, according to U.S. Sen. Kirsten Gillibrand (D-NY). "Trump's buyout offer would have devastating consequences for the tens of millions of Americans who rely on Social Security,"&nbsp; <a href="https://www.gillibrand.senate.gov/news/press/release/gillibrand-slams-trump-policy-that-would-gut-social-security-administration-make-it-harder-for-seniors-to-receive-benefits/">she said</a>.
The administration has offered early retirement incentives to federal employees, leading to concerns that staff shortages could slow down Social Security claims processing. The agency already faces long wait times, with average phone support delays reaching 45 minutes and disability benefit determinations taking up to 230 days.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
<h2 class="wp-block-heading">What This Means for Social Security Recipients</h2>
For now, <a href="https://www.benzinga.com/personal-finance/25/01/42920272/despite-a-modest-50-monthly-increase-in-2025-americans-worry-social-security-may-not-survive-past-2034">Social Security beneficiaries</a> continue to receive their payments as scheduled. But watchdog organizations and lawmakers will be closely monitoring DOGE's role in federal payment processing. Advocacy groups have called for legal action to prevent any potential interference with Social Security benefits, and pending lawsuits may determine the future scope of DOGE's authority over federal funds.
While no immediate disruptions have been reported, the uncertainty surrounding Musk's access to Treasury operations leaves many retirees and beneficiaries on edge. As discussions continue in Washington, Social Security recipients are advised to stay informed and reach out to their representatives to voice their concerns.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>

Personal Finance

'Social Security Beneficiaries Have Every Reason To Be Alarmed' By Musk's Access To U.S. Department Of Treasury Payment System

On Monday, TC BioPharm (Holdings) PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) announced the first Cohort B patient in the ACHIEVE Phase 2B UK trial of TCB008 in Acute Myeloid Leukemia has completed the full dosing regimen.
The ACHIEVE trial is an open-label Phase 2 study evaluating the efficacy and safety of TCB008.
The trial is focused on assessing TCB008&#8217;s effectiveness and tolerability in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS/AML) with refractory or relapsed conditions.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/12/42551325/exclusive-penny-stock-tc-biopharm-proposes-special-stock-dividend" rel="noreferrer noopener">EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend</a>
Cohort B recruits patients who have achieved remission following previous treatment yet continue to have a detectable or minimal residual disease (MRD).
Recruitment into Cohort B was initiated during the fourth quarter of 2024, ahead of the company&#8217;s anticipated schedule.
The first Cohort B patient received their dose in October 2024.
The initial Cohort B patient has completed the dosing regimen, received all four planned doses of TCB008, and is expected to receive an additional fifth dose.
Enrolment of a second Cohort B patient has also been initiated.
The trial&#8217;s safety objectives and endpoints evaluate patient responses to TCB008, including grading of adverse events experienced and the incidence and severity of cytokine release syndrome and neurotoxicity.
A review of preliminary data shows no drug-related adverse events following cumulative infusions of TCB008, containing <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42615458/tcbp-advances-achieve-phase-2b-clinical-trial-with-final-dosing-of-3-patients" rel="noreferrer noopener">up to a billion cells</a>.
&#8220;We expect to complete enrolment in the second cohort in the first half of 2025, with data readout anticipated later this year,&#8221; said&nbsp;&lt; Bryan Kobel, TC BioPharm&#8217;s CEO.
In December, TC BioPharm announced it advanced negotiations with both of its previously aforementioned acquisition candidates.
Earlier, TCBP announced the execution of non-binding letters of intent as part of its M&amp;A strategy to expand its therapeutic platform. The company continues to pursue its expansion strategy via acquisition, specifically in new indications and new <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42742389/tcbp-provides-update-on-acquisition-strategy-and-current-targets" rel="noreferrer noopener">cell therapy modalities</a>.
Price Action: TCBP stock closed at $0.20 on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43570917/cloudflares-ai-expansion-and-enterprise-growth-set-the-stage-for-big-gains-analysts" target="_blank" rel="noreferrer noopener">Buy Cloudflare Or Sell? Analysts Vary Over Sales Acceleration And Business Momentum</a></li>
</ul>

Biotech

News

Health Care

Exclusives

General

TCBP

EXCLUSIVE: Nano-Cap TC BioPharm Concludes Initial Cohort B Patient Dosing In Mid-Stage Leukemia Trial, Data Readout By End Of 2025

Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) has outperformed the market over the past 20 years by 2.28% on an annualized basis producing an average annual return of 10.65%. Currently, Global Payments has a market capitalization of $27.89 billion. 
Buying $100 In GPN: If an investor had bought $100 of GPN stock 20 years ago, it would be worth $757.82 today based on a price of $109.60 for GPN at the time of writing.
<h3>Global Payments's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739196911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Global Payments 20 Years Ago Would Be Worth This Much Today

Market-Moving Exclusives

EXCLUSIVE: TC BioPharm Tells Benzinga Co. Announces Successful Completion Of Initial Cohort B Patient Dosing In The ACHIEVE Clinical Trial

Contracts

AVAV

AeroVironment Subsidiary Arcturus UAV Awarded $181M Contract From Danish Defence For 10-Year JUMP 20 Aircraft System Program To Enhance ISR Operations

Guggenheim analyst Debjit Chattopadhyay reiterates Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) from Buy to Buy.

Reiteration

Analyst Ratings

RZLT

Guggenheim Reiterates Buy on Rezoluteto Buy

Truist Securities analyst Peter Osterland maintains Minerals Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>) with a Buy and lowers the price target from $103 to $101.

Price Target

Truist Securities Maintains Buy on Minerals Technologies, Lowers Price Target to $101

On Monday, Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) stated that it would require a significant increase in orders from India before establishing a final civil aircraft assembly line in the country.
&#8220;The business case for final assembly in any region must be far larger than what the Indian market currently supports,&#8221; said Salil Gupte, president of Boeing India and South Asia, in an interview with <a href="https://www.reuters.com/business/aerospace-defense/boeing-signals-more-orders-needed-before-setting-up-assembly-line-india-2025-02-10/" target="_blank" rel="noreferrer noopener">Reuters</a>. &#8220;It requires many more airplanes than are being bought in India today.&#8221;
Gupte emphasized a step-by-step approach to expanding final assembly in India, highlighting the need for market growth in the region.
Indian airlines, including Air India and IndiGo, have around 1,800 aircraft on order from global manufacturers with 130 jets set for delivery this year, according to Cirium Ascend.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/02/43581856/us-greenlights-7-4-billion-military-deal-with-israel-key-weapons-deals-explained" rel="noreferrer noopener">US Greenlights $7.4 Billion Military Deal With Israel: Key Weapons Deals Explained</a>.
Last week, Boeing <a target="_blank" href="https://boeing.mediaroom.com/news-releases-statements?item=131523" rel="noreferrer noopener">projected that India and South Asia&#8217;s commercial airplane fleet</a> will nearly quadruple over the next 20 years, driven by more than 7% annual air traffic growth through 2043. This expansion will be fueled by economic growth, improved connectivity, and supportive air travel policies.
The forecast also highlights rising demand for fuel-efficient aircraft, with nearly 90% of deliveries expected to be single-aisle jets like the 737 MAX. Widebody fleets will expand as airlines develop long-haul routes, while cargo freighter fleets are set to grow five-fold. Additionally, the region will see the world&#8217;s fastest-growing demand for aviation professionals, with pilot, cabin crew and technician needs projected to quadruple to 129,000.
Price Action: At the last check on Monday, BA shares were trading higher by 0.47% at $182.35 premarket.
Photo: Shutterstock

Boeing Seeks More Orders Before Committing To Indian Aircraft Assembly Line

Guggenheim analyst Debjit Chattopadhyay reiterates Centessa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTA#NASDAQ">CNTA</a>) from Buy to Buy.

CNTA

Guggenheim Reiterates Buy on Centessa Pharmaceuticalsto Buy

Truist Securities analyst Michael Swartz maintains LCI Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCII#NYSE">LCII</a>) with a Hold and raises the price target from $102 to $108.

LCII

Truist Securities Maintains Hold on LCI Indus, Raises Price Target to $108

Offerings

SNCY

CORRECTION: Reported Earlier, Sun Country Airlines Prices Secondary Public Offering Of 6,346,105 Shares Of Its Common Stock By An Affiliate Of Certain Investment Funds Managed By Affiliates Of Apollo Global Management

Guggenheim analyst Shahriar Pourreza reiterates Eversource Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ES#NYSE">ES</a>) from Buy to Buy.

Guggenheim Reiterates Buy on Eversource Energyto Buy

Truist Securities analyst Jailendra Singh reiterates IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) with a Buy and raises the price target from $261 to $263.

Truist Securities Reiterates Buy on IQVIA Hldgs, Raises Price Target to $263

Loews Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/L#NYSE">L</a>) reported a fourth-quarter revenue of $4.55 billion <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43587300/loews-corporation-reports-net-income-of-187-million-for-the-fourth-quarter-of-2024-and-1-414-milli" rel="noreferrer noopener">compared to $4.26 billion a year ago.</a>
EPS was $0.86, down from $1.99 a year ago. Net income fell to $187 million from $446 million a year ago.
This year&#8217;s&nbsp;fourth quarter&nbsp;results include a pension settlement charge for CNA Financial Corporation&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>)&nbsp;of&nbsp;$265 million, after-tax and noncontrolling interests, which was previously reported in&nbsp;October 2024.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
CNA Financial&#8217;s revenue contribution increased to $3.69 billion from $3.51 billion a year ago, and net income fell to $19 million from $336 million a year ago. Excluding the pension charge, CNA&#8217;s net income attributable to Loews was&nbsp;$284 million&nbsp;compared to&nbsp;$336 million.
Boardwalk Pipelines segment&#8217;s revenues rose to $577 million from $511 million in the year-ago quarter, and net income rose to $145 million from $92 million the prior year.
Boardwalk Pipelines saw year-over-year improvement, driven by higher fourth-quarter 2024 revenues from re-contracting at increased rates and the completion of recent growth projects.
Loews Hotels&#8217; revenues rose to $240 million from $210 million year-over-year, while net income fell to $27 million from $32 million, impacted by higher depreciation and interest costs from the Arlington Hotel and Convention Center opening.
As of December 31, 2024, the parent&nbsp;company had $3.3 billion in cash and investments and $1.8 billion in debt.
Loews repurchased 4.2 million shares for $349 million in the quarter, totaling 7.7 million for $611 million in 2024. So far, in the first quarter of 2025, the company has repurchased 1.9 million shares for $164 million.
Price Action: L shares traded higher by 5% at $91.11 premarket at last check Monday.
Image via Shutterstock.

Earnings

Equities

Movers

Loews Q4: Earnings Take A Hit On Pension Charge, But Pipelines And Buybacks Offer Silver Lining

Barclays analyst Luke Sergott maintains Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) with a Overweight and lowers the price target from $69 to $65.

BRKR

Barclays Maintains Overweight on Bruker, Lowers Price Target to $65

Guggenheim analyst Michael Schmidt maintains ORIC Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIC#NASDAQ">ORIC</a>) from Buy to Buy.

ORIC

Guggenheim Maintains Buy on ORIC Pharmaceuticalsto Buy

McDonald's Exec Says Results Took A Hit In Early Nov After E.Coli Outbreak, But Improved Sequential Through Q4, And Has Continued Into Q1

Fox Corporation ("FOX" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>, FOX))) today announced its acquisition of Red Seat Ventures, a leading business in the creator economy that powers talent across a range of genres as they build their direct-to-consumer media businesses. Red Seat Ventures will operate as a standalone entity within FOX's Tubi Media Group. Paul Cheesbrough, CEO of Tubi Media Group, assumes the role of Chairman, Red Seat Ventures.
The Red Seat Ventures executive team, led by founding partners Chris Balfe and Kevin Balfe, will continue to lead and operate the business.

FOXA

Fox Corp. Acquires Red Seat Ventures; No Financial Terms Disclosed

WIIM

LYFT

Lyft shares are trading higher following a TechCrunch report indicating the company will launch robotaxis as soon as 2026.

<a href="https://techcrunch.com/2025/02/10/lyft-to-launch-mobileye-powered-robotaxis-as-soon-as-2026-starting-with-dallas/" title="https://techcrunch.com/2025/02/10/lyft-to-launch-mobileye-powered-robotaxis-as-soon-as-2026-starting-with-dallas/">https://techcrunch.com/2025/02/10/lyft-to-launch-mobileye-powered-robotaxis-as-soon-as-2026-starting-with-dallas/</a>

Comments

Veridis Environment

News

Latest news for Veridis Environment (OTC:VRDDF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga